KENNEDY CAPITAL MANAGEMENT LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 194 filers reported holding HAEMONETICS CORP in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
KENNEDY CAPITAL MANAGEMENT LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2014$2,117,000
-76.0%
60,635
-75.8%
0.04%
-74.4%
Q2 2014$8,825,000
-0.4%
250,141
-8.0%
0.16%
-1.8%
Q1 2014$8,862,000
-24.2%
271,919
-2.0%
0.17%
-22.7%
Q4 2013$11,684,000
-8.9%
277,335
-13.7%
0.22%
-12.9%
Q3 2013$12,820,000
-7.0%
321,458
-3.6%
0.25%
-11.4%
Q2 2013$13,787,000333,4110.28%
Other shareholders
HAEMONETICS CORP shareholders Q2 2013
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders